LTS-Academy - OTF as a viable dosage form for pain relief

LTS-Academy: OTF as a viable dosage form for pain relief


August 14, 2022


Our LTS Academy session reports on the latest research in the field of pain and ketamine. We show that oral thin films (OTFs) are a convenient and attractive alternative dosage form for ketamine and other compounds. We discuss promising results of a pharmacokinetic human study performed with transmucosal fast-dissolving oral thin films that contain Esketamine, the positive effect seen in different pain models and the outcome of the used PK/PD modelling. Finally, we also have a view on opportunities in an unsaturated growing market.

Language: EN

Presented by:
Dr. Patrick Mohr, Corporate Vice President Head of Pharmaceutical Development II at LTS
Prof Dr. Albert Dahan, professor for Anesthesiology at the Leiden University
Dr. Florian Hammes, Director Head of Laboratory at LTS
Dr. May Pidding, Director LTS Business Development North America